Clinical Trial Update: PKC412 and 5-Azacytidine [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating PKC412 (midostaurin) in combination with 5-azacytidine for leukemia has completed recruitment with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• 5-Azacytidine (5-azacytidine)
• PKC412

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-11-07